Edmond de Rothschild Holding’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.3K | Sell |
188
-130
| -41% | -$42.4K | ﹤0.01% | 439 |
|
|
2025
Q1 | $85.9K | Buy |
318
+49
| +18% | +$13.2K | ﹤0.01% | 426 |
|
|
2024
Q4 | $63.3K | Buy |
+269
| New | +$63.3K | ﹤0.01% | 482 |
|
|
2024
Q3 | – | Sell |
-53,050
| Closed | -$12.9M | – | 630 |
|
|
2024
Q2 | $12.9M | Sell |
53,050
-12,000
| -18% | -$2.92M | 0.22% | 106 |
|
|
2024
Q1 | $9.72M | Buy |
65,050
+49,250
| +312% | +$7.36M | 0.16% | 128 |
|
|
2023
Q4 | $3.02M | Buy |
+15,800
| New | +$3.02M | 0.05% | 202 |
|
|
2018
Q4 | – | Sell |
-208
| Closed | -$18K | – | 665 |
|
|
2018
Q3 | $18K | Hold |
208
| – | – | ﹤0.01% | 670 |
|
|
2018
Q2 | $20K | Hold |
208
| – | – | ﹤0.01% | 664 |
|
|
2018
Q1 | $25K | Hold |
208
| – | – | ﹤0.01% | 675 |
|
|
2017
Q4 | $26K | Hold |
208
| – | – | ﹤0.01% | 680 |
|
|
2017
Q3 | $24K | Hold |
208
| – | – | ﹤0.01% | 705 |
|
|
2017
Q2 | $17K | Hold |
208
| – | – | ﹤0.01% | 722 |
|
|
2017
Q1 | $11K | Hold |
208
| – | – | ﹤0.01% | 755 |
|
|
2016
Q4 | $8K | Hold |
208
| – | – | ﹤0.01% | 757 |
|
|
2016
Q3 | $14K | Hold |
208
| – | – | ﹤0.01% | 754 |
|
|
2016
Q2 | $12K | Hold |
208
| – | – | ﹤0.01% | 737 |
|
|
2016
Q1 | $13K | Hold |
208
| – | – | ﹤0.01% | 733 |
|
|
2015
Q4 | $20K | Hold |
208
| – | – | ﹤0.01% | 705 |
|
|
2015
Q3 | $17K | Hold |
208
| – | – | ﹤0.01% | 717 |
|
|
2015
Q2 | $25K | Buy |
+208
| New | +$25K | ﹤0.01% | 699 |
|